Name: 5th Annual MarketsandMarkets Neuroscience R&D Technologies Conference
Start: 2019-10-03
End: 2019-10-04
Location: Radisson Blu Edwardian, Grafton Hotel, London

CONFERENCE AGENDA

Registration	08:15 - 08:55
Welcome note from MarketsandMarkets Conferences	08:55 - 09:00
Opening Remarks from the Chairman	09:00 - 09:10
Keynote Presentation: Stimulating neurogenesis for treatment of neurodegenerative diseases Georg Terstappen , Chief Scientific Officer, OxStem	09:10 - 09:40
Role of Human IPSCs in Neuroscience and Pain Research
Deciphering the Identity of DIPG Cells to Develop Targeted Therapy Utilizing Genetically Engineered hNSCs Yang (Ted) Teng, Director, Laboratory of SCI, Stem Cell & Neurofacilitation Research, Harvard University	09:40 - 10:10
How can we achieve better translation from in vitro to the clinic in neuroscience? Paul Karila, CSO, Cellectricon	10:10 - 10:25
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:25 - 11:10
A Human iPSC-based Technology Platform for Amyotrophic Lateral Sclerosis Neuroinflammation Drug Discovery Steven Biesmans , Senior Scientist, UCB	11:10 - 11:40
AI-driven phenotypic drug discovery delivers first-in-class, clinically effective neuropsychiatric treatments Emer Leahy , CEO , Psychogenics	11:40 - 12:10
Introduction to Axols capabilities and how they can support your research Nicholas Clare, Head, Customer Solutions, Axol Bioscience	12:10 - 12:40
Cellular models of Parkinson’s disease using toxins involve different dopaminergic neuron death processes: impact on drug screening Noelle Callizot, Co-Founder, CSO, Neuro-Sys	12:40 - 13:10
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:10 - 14:10
Human iPSC-derived cells: a powerful tool for neuropathic pain disease modelling Silvia Cainarca, Principal Investigator, Project Leader, IMI2 project -NGN-PET, Italy	14:10 - 14:40
Degenerative synaptopathies – progress and challenges Frank Hirth , Group Leader Neural Circuits and , Behaviour King’s College London, UK	14:40 - 15:10
Optimizing next-generation drug development: RNA medicine meets systems biology Winston Hide , C0-Director Non-Coding RNA Core, Harvard University	15:10 - 15:40
Afternoon Refreshments and Poster Presentation \| One-to-One Networking Meetings	15:40 - 16:25
Preclinical development of new therapeutics: Opportunities and challenges. Arshad Majid , Professor of Cerebrovascular Neurology, Director, Comprehensive Cerebrovascular Research unit (CCRU), University of Sheffield	16:25 - 16:55
From Translational Science in an Academic Setting to Commercial R&D in a Corporate Setting: Crossing the ‘Valley of Death’ David Taggart , Chief Operating Officer, Glycyx Therapeutics, USA	16:55 - 17:25
Panel: Challenges in the translation of pre-clinical to clinical research in CNS drug discovery	17:25 - 17:55
Closing Remarks from the Chairman	17:55 - 18:00
Drinks Reception & Networking	18:00 - 19:00

Registration	08:15 - 08:55
Welcome note from MnM Conferences	08:55 - 09:00
Opening Remarks from the Chairman Frank Hirth , Group Leader Neural Circuits and , Behaviour King’s College London, UK	09:10 - 09:15
Keynote Presentation: Cell-type specific profiling of human brain for novel therapeutic development Xiao Xu, Co-Founder, Cerevance, UK	09:15 - 09:45
Biomarkers and CNS Models
Strategies to enhance memory in old age and dementia Karl Peter Giese, Professor, Neurobiology of Mental Health, King’s College London	09:45 - 10:15
TMS electro-diagnostic markers as a clinical readout for testing novel CNS therapeutics Isabella Premoli, Research Lead, The Science Behind	10:15 - 10:45
Morning Refreshments and Poster Presentation \| One-to-One Networking Meetings	10:45 - 11:35
Why is Pharma so scared of psychiatric drug discovery is the fear justified? Mark Tricklebank, Wellcome Trust Research Fellow, Neuroimaging, King’s College London, UK	11:35 - 12:05
A new functional in vitro assay for screening of antipsychotics Olaf Schroder, CEO, Neuroproof, Germany	12:05 - 12:35
Neuromodulation and Deep Brain Stimulation
Neuroengineering solutions for brain repair Michela Chiappalone , Associate Professor, University of Genova	12:35 - 13:05
Lunch and Poster Presentation \| One-to-One Networking Meetings	13:05 - 14:05
Brain informatics – a gateway to cutting-edge brain research Mufti Mahmud, Senior Lecturer, Computing & Technology, Nottingham Trent University,	14:05 - 14:35
Closing remarks from the Chairman	14:35 - 14:40
Afternoon Refreshments and End of Conference	14:40 - 16:00